Clinical data from patients with untreated aggressive Non-Hodgkin's-Lymphoma aged 61-80 years without relevant concomittant diseases

LHA-ID
7Q0CTG2N72-3
Motivation

Improvement of efficacy of chemotherapy with CHOP-14 by additional therapy with the monoclonal antibody Rituximab and/or increase in cycle number from 6 to 8, measured by time to treatment failure

Description

complete clinical data set for the clinical trial

Study Design

randomised, open-label, multi-centric, prospective phase-III-trial; randomised in 6 vs. 8 cycles of CHOP-14 with or without Rituximab

Publication Date
Contact
Marita Ziepert
Version Number
1.0
Sample Size
n=1222; 6xCHOP-14 (n=307); 8xCHOP-14 (n=305); 6xR-CHOP-14 (n=306); 8xR-CHOP-14 (n=304)